Women with psoriasis show shorter drug survival for biologics, including IL-17/23 inhibitors, due to lower satisfaction and more frequent adverse events. The study used the Dutch BioCAPTURE registry ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback